Transcriptional Repression of SIRT3 Potentiates Mitochondrial Aconitase Activation to Drive Aggressive Prostate

Abhisha Sawant Dessai1, Mayrel Palestino Dominguez1, Uan-I Chen2

  • 1Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.

Cancer Research
|October 29, 2020
PubMed

Insights

Androgen receptor (AR) and SRC-2 repress SIRT3, boosting ACO2 activity in aggressive prostate cancer. Blocking SRC-2 reactivates SIRT3, inhibiting metastasis and offering a potential therapy.

Area of Science:

  • Molecular Oncology
  • Cancer Metabolism
  • Metastasis Research

Background:

  • Metabolic dysregulation is a hallmark of cancer, but oncogenic signals driving metastatic adaptation are not fully understood.
  • Sirtuin 3 (SIRT3), a mitochondrial deacetylase, plays a role in metabolic regulation, but its repression in cancer and impact on metastasis are unclear.

Purpose of the Study:

  • To investigate the role of androgen receptor (AR), steroid receptor coactivator-2 (SRC-2), and mitochondrial aconitase (ACO2) in prostate cancer progression and metastasis.
  • To elucidate the regulatory axis connecting nuclear signaling (AR/SRC-2) to mitochondrial metabolism (ACO2) and its impact on metastatic competence.

Main Methods:

  • Investigated the transcriptional regulation of SIRT3 by AR and SRC-2.
  • Assessed the enzymatic activity and regulatory acetylation of ACO2.
  • Utilized genetic ablation of ACO2 and depletion of SRC-2 in prostate cancer models.
  • Analyzed human prostate tumor samples for ACO2 activity, SRC-2, and SIRT3 expression.

Main Results:

  • AR and SRC-2 repress SIRT3 expression, leading to increased ACO2 activity, which promotes lipogenesis and prostate cancer progression.
  • Acetylation at Lys258 is crucial for ACO2 activity; SIRT3 deacetylates and regulates ACO2.
  • SRC-2 depletion reactivates SIRT3, reduces acetylated ACO2, and abolishes bone metastasis in a mouse model.

Conclusions:

  • The nuclear-mitochondrial regulatory axis involving AR, SRC-2, SIRT3, and ACO2 is critical for prostate cancer metastatic competence.
  • Elevated ACO2 activity and specific expression patterns of SRC-2 and SIRT3 are hallmarks of metastatic prostate cancer.
  • Therapeutic strategies targeting SRC-2 to enhance SIRT3 expression hold promise for treating metastatic prostate cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.6K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.5K